A breakthrough alternative to antibiotics for preventing and curing infectious diseases at Intensive Care Units

Project description

Introducing a novel approach to combat antimicrobial-resistant pathogens

It is estimated that antimicrobial resistance of pathogens could become the major cause of death by 2050. Many gram-negative bacteria are especially life-threatening due to their antibiotic resistance and high presence in hospital intensive care units. The EU-funded HAIKU project aims to confirm the preclinical development process and review market conditions for RA-01, a novel drug that prevents internal bacterial infection by removing specific antibodies. This will lead to the next stage of RA-01 clinical trials, licensing and market delivery. The project will enable the prevention of infectious diseases in intensive care units, thus saving lives, reducing length of hospital stays and significantly cutting healthcare expenses.

Fields of science

• medical and health sciences › health sciences › infectious diseases
• medical and health sciences › clinical medicine › critical care medicine
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › antibiotics
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug resistance › multidrug resistance
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug resistance › antibiotic resistance

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

REMAB THERAPEUTICS SL

Net EU contribution

€ 50 000,00

Address

C Feixa Llarga Sn Edificio Biopol Office 3
08907 Hospitalet De Llobregat
Spain

Region

Este › Cataluña › Barcelona

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 21 429,00